a b s t r a c t Paget’s disease of bone is the paradigm of bone focal distortion with accelerated bone turnover. Over the years, a number of different drugs have been used to control its activity but, since bisphosphonates were introduced for the treatment of the disease, they have become the preferred treatment. This review will update the therapeutic indications, available drugs and therapeutic response monitoring
Paget’s disease of bone (PDB) is a metabolic bone disease characterized by increased bone reso...
Bisphosphonates are pharmacological compounds that have been used for the prevention and treatment o...
Abstract: Paget’s disease of bone (PDB) is a condition characterized by excessive and abnormal bone ...
Paget's disease of bone (PDB) is a chronic bone remodelling disorder characterized by increased oste...
Paget's disease of bone is a chronic disorder of unknown etiology that can result in enlarged and mi...
Introduction: Paget’s disease of bone (PDB) is a focal bone disorder caused by a marked dysregulatio...
There has been a dramatic change in the therapeutic approach to patients with Paget's disease of bon...
Paget's disease of bone (PDB) affects 1%-3% of the population and is associated with increased risk ...
Paget's disease of bone (PDB) is a potentially crippling condition. Pain, fracture, spinal stenosis,...
Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally ...
Paget's disease of bone is a condition of unknown etiology characterized by excessive and abnormalbo...
Paget\u27s disease of the bone is characterized by a focal increase in the rate of bone turnover, wh...
The main biologic action of bisphosphonates consists of the inhibition of osteoclastic bone resorpti...
Paget's disease of bone is characterized by an anarchic bone turnover starting with excessive resorp...
Paget\u27s disease of bone is a localized skeletal disorder, which is more common in England and in ...
Paget’s disease of bone (PDB) is a metabolic bone disease characterized by increased bone reso...
Bisphosphonates are pharmacological compounds that have been used for the prevention and treatment o...
Abstract: Paget’s disease of bone (PDB) is a condition characterized by excessive and abnormal bone ...
Paget's disease of bone (PDB) is a chronic bone remodelling disorder characterized by increased oste...
Paget's disease of bone is a chronic disorder of unknown etiology that can result in enlarged and mi...
Introduction: Paget’s disease of bone (PDB) is a focal bone disorder caused by a marked dysregulatio...
There has been a dramatic change in the therapeutic approach to patients with Paget's disease of bon...
Paget's disease of bone (PDB) affects 1%-3% of the population and is associated with increased risk ...
Paget's disease of bone (PDB) is a potentially crippling condition. Pain, fracture, spinal stenosis,...
Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally ...
Paget's disease of bone is a condition of unknown etiology characterized by excessive and abnormalbo...
Paget\u27s disease of the bone is characterized by a focal increase in the rate of bone turnover, wh...
The main biologic action of bisphosphonates consists of the inhibition of osteoclastic bone resorpti...
Paget's disease of bone is characterized by an anarchic bone turnover starting with excessive resorp...
Paget\u27s disease of bone is a localized skeletal disorder, which is more common in England and in ...
Paget’s disease of bone (PDB) is a metabolic bone disease characterized by increased bone reso...
Bisphosphonates are pharmacological compounds that have been used for the prevention and treatment o...
Abstract: Paget’s disease of bone (PDB) is a condition characterized by excessive and abnormal bone ...